These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27230481)

  • 41. Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors.
    Chen JJ; Sohn EH; Folk JC; Mahajan VB; Kay CN; Boldt HC; Russell SR
    Retina; 2014 Jul; 34(7):1400-6. PubMed ID: 24451922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A case of peripheral retinal telangiectasis complicated by retinal detachment].
    Lejoyeux R; Le Mer Y
    J Fr Ophtalmol; 2019 Oct; 42(8):e359-e361. PubMed ID: 31202774
    [No Abstract]   [Full Text] [Related]  

  • 43. Intravitreal bevacizumab in advanced-stage neovascular age-related macular degeneration with visual acuity lower than 20/200.
    Parodi MB; Cascavilla M; Papayannis A; Kontadakis DS; Bandello F; Iacono P
    Arch Ophthalmol; 2012 Jul; 130(7):934-5. PubMed ID: 22776937
    [No Abstract]   [Full Text] [Related]  

  • 44. Macular Telangiectasia Type 2 Without Clinically Detectable Vasculopathy.
    Gillies MC; Mehta H; Bird AC
    JAMA Ophthalmol; 2015 Aug; 133(8):951-4. PubMed ID: 26067680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SUBRETINAL NEOVASCULARIZATION IN MACULAR TELANGIECTASIA TYPE 2: OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY AND TREATMENT RESPONSE.
    Tan GS; Kuehlewein L; Sadda SR; Sarraf D; Schwartz SD
    Retin Cases Brief Rep; 2015; 9(4):286-9. PubMed ID: 26288110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reading performance with different contrast characters in patients with central serous chorioretinopathy.
    Fujita K; Matsumoto CS; Mizutani Y; Imamura Y; Tanaka E; Satofuka S; Shinoda K; Mizota A; Oda K; Yuzawa M
    Acta Ophthalmol; 2012 Nov; 90(7):e575-7. PubMed ID: 22405126
    [No Abstract]   [Full Text] [Related]  

  • 47. Intravitreal bevacizumab for perifoveal telangiectasia.
    Jonas JB; Libondi T; von Baltz S; Beutelspacher S
    Acta Ophthalmol; 2011 Nov; 89(7):e607-8. PubMed ID: 20946328
    [No Abstract]   [Full Text] [Related]  

  • 48. OUTER RETINA CAPILLARY INVASION AND ELLIPSOID ZONE LOSS IN MACULAR TELANGIECTASIA TYPE 2 IMAGED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Gaudric A; Krivosic V; Tadayoni R
    Retina; 2015 Nov; 35(11):2300-6. PubMed ID: 26441270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Holz FG; Scholl HP
    Ophthalmology; 2007 Sep; 114(9):1736-42. PubMed ID: 17822979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography.
    Spaide RF; Klancnik JM; Cooney MJ
    JAMA Ophthalmol; 2015 Jan; 133(1):66-73. PubMed ID: 25317692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Idiopathic macular telangiectasia type 2, stage V or proliferative stage: Multimodal imaging.
    Sánchez-Vicente JL; de Las Morenas-Iglesias J; González-Jáuregui-López B; Rueda-Rueda T; Espiñeira-Periñán Á; López-Herrero F
    J Fr Ophtalmol; 2021 Nov; 44(9):1447-1451. PubMed ID: 34420799
    [No Abstract]   [Full Text] [Related]  

  • 52. Diagnostic and therapeutic challenges.
    Hatef E; Ibrahim M; Nguyen QD; Do DV; Davis MJ; Rezaei KA; Kovach JL
    Retina; 2011 Jun; 31(6):1218-23. PubMed ID: 21386757
    [No Abstract]   [Full Text] [Related]  

  • 53. Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography.
    Park SJ; Woo SJ; Park KH; Hwang JM; Chung H
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3673-9. PubMed ID: 20164460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longer-term outcomes of a prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
    Chang LK; Spaide RF; Klancnik JM; Sorenson J; Slakter JS; Freund KB; Yannuzzi LA; Tseng JJ; Klein R
    Retina; 2011 May; 31(5):821-8. PubMed ID: 21317833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2.
    Roisman L; Rosenfeld PJ
    Dev Ophthalmol; 2016; 56():146-58. PubMed ID: 27022942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spontaneous resolution of retinal vascular abnormalities and macular oedema in facioscapulohumeral muscular dystrophy.
    Lindner M; Holz FG; Charbel Issa P
    Clin Exp Ophthalmol; 2016 Sep; 44(7):627-628. PubMed ID: 26933772
    [No Abstract]   [Full Text] [Related]  

  • 57. Local retinal sensitivity in relation to specific retinopathy lesions in diabetic macular oedema.
    Soliman W; Hasler P; Sander B; Larsen M
    Acta Ophthalmol; 2012 May; 90(3):248-53. PubMed ID: 20809906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinal fluorescein and indocyanine green angiography and spectral-domain optical coherence tomography findings in acute retinal pigment epitheliitis.
    Baillif S; Wolff B; Paoli V; Gastaud P; Mauget-Faÿsse M
    Retina; 2011 Jun; 31(6):1156-63. PubMed ID: 21293312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia.
    Takayama K; Ooto S; Tamura H; Yamashiro K; Otani A; Tsujikawa A; Yoshimura N
    Eye (Lond); 2010 Sep; 24(9):1492-7. PubMed ID: 20431610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion.
    Hoerster R; Muether PS; Sitnilska V; Kirchhof B; Fauser S
    Retina; 2014 Sep; 34(9):1767-73. PubMed ID: 24936942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.